Skip to main content

Eydelman Mikhail's Form 4 filing

Vaxcyte, Inc. (PCVX) · filed Jan 7, 2025

Accession no.
0001649094-25-000004
Filed
Jan 7, 2025
Trade date
Jan 6, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $427.9K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Eydelman MikhailCIK 0001918033Officer (SVP, GEN COUNSEL & CORP SEC)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 6, 2025Common StockMOption exerciseAcquired+5,000$21.41+$107,05033,222Direct
Jan 6, 2025Common StockSSaleDisposed−954$84.86−$80,956.4432,268Direct
Jan 6, 2025Common StockSSaleDisposed−3,921$85.73−$336,147.3328,347Direct
Jan 6, 2025Common StockSSaleDisposed−125$86.52−$10,81528,222Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 6, 2025Common StockMOption exerciseDisposed−5,000$0.00$0154,497Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)